Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 17, 2013
Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry today announced that Kristin Arnold, Ph.D. has joined the company as vice president, product development ...
read more
Tuesday, February 05, 2013
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed, subject to certain closing conditions, to acquire the Clinical Trial Services ...
read more
Thursday, February 07, 2013
The Scientific and Regulatory Consulting business of Cardinal Health Specialty Solutions (Beckloff Associates) will provide regulatory support to the National Institutes of Health’s (NIH) Therapeutics for Rare and Neglected Diseases (TRND) program ...
read more
Wednesday, February 13, 2013
Recipharm and PledPharma announce FDA approval of an IND application for Phase IIb clinical trial with PledOx, PLIANT, in the U.S. The material for PLIANT has been manufactured by Recipharm Pharmaceutical Development.
read more
Friday, February 15, 2013
SGS expands its Clinical Pharmacology Unit in Antwerp, Belgium with a Viral Challenge Testing facility including a 12-bed, Biosafety Level 2-Q compliant, quarantine facility.
read more
Friday, February 15, 2013
Metrics Inc. has added a new formulation scientist to its growing staff of pharmaceutical chemists.
read more
Friday, February 22, 2013
The first Theorem Think Tank on drug development will be held in Boston from 3-7 p.m., March 7. Led by noted leaders in their respective fields, the six sessions offer insight into key aspects of the drug and medical device development process for ...
read more
Tuesday, February 26, 2013
Intelsius, a global designer, manufacturer and distributor of environmentally sustainable, temperature-controlled and regulatory-compliant packaging solutions, announced today that Stephen Healy has joined the company as European Sales Director. Mr. ...
read more
Thursday, February 28, 2013
Camargo Pharmaceutical Services, the 505(b)(2) experts, is teaming with XenoTech, a leading contract research organization in the drug metabolism field, to present a webinar March 21 for drug developers who want to learn how to use the 505(b)(2) ...
read more
Thursday, February 28, 2013
Theorem Clinical Research has released two site-level reference booklets for clinical research sites that explain and condense critical International Conference on Harmonisation guidelines related to Good Clinical Practice for the conduct of trials.
read more
Thursday, February 28, 2013
Cenduit LLC, a leading global provider of patient randomization and clinical supplies management services, has announced the expansion of its Durham, NC, headquarters and its office in Basel, Switzerland. The expansion adds substantial space to the ...
read more
Roche today announced that it is expanding access to its clinical trial data for third party researchers. Roche will work with an independent body of recognised experts to evaluate and approve requests to access anonymised patient-level data. Roche ...
read more
Wednesday, March 13, 2013
Theorem Clinical Research, which continues to enhance its ability to help research sponsors optimize trial conduct, recently expanded its Medidata services partnership by obtaining accreditation for Medidata Balance and Medidata Rave Targeted Source ...
read more
Wednesday, March 13, 2013
Merck, known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's ...
read more
BioClinica, Inc., a global provider of clinical trial management services, announced today that JLL Partners and Ampersand Capital Partners, two leading middle market private equity firms, have completed their acquisition of BioClinica and CoreLab ...
read more